Current research on chronic active Epstein-Barr virus infection in Japan. (Q51849571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Current research on chronic active Epstein-Barr virus infection in Japan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Tomohiro Morio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Shigeyoshi Fujiwara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ken-ichi Imadome

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ayako Arai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Eiichi Kodama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Norio Shimizu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hiroshi Wakiguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

published in

Pediatrics International

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

159-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

8 March 2020

cites work

1 reference

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

Chronic, symptomatic Epstein-Barr virus infections

21 January 2018

1 reference

The chronic mononucleosis syndrome

21 January 2018

1 reference

Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome

21 January 2018

1 reference

Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?

21 January 2018

1 reference

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

21 January 2018

1 reference

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

21 January 2018

1 reference

Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection

21 January 2018

1 reference

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

21 January 2018

1 reference

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

21 January 2018

1 reference

Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.

21 January 2018

1 reference

Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome

21 January 2018

1 reference

Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM.

21 January 2018

1 reference

Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection

21 January 2018

1 reference

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

21 January 2018

1 reference

Prognostic factors for chronic active Epstein-Barr virus infection

21 January 2018

1 reference

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

21 January 2018

1 reference

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome

21 January 2018

1 reference

The association of latent Epstein-Barr virus infection with hydroa vacciniforme

21 January 2018

1 reference

Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells

21 January 2018

1 reference

Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease

21 January 2018

1 reference

Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites

21 January 2018

1 reference

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

21 January 2018

1 reference

T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.

21 January 2018

1 reference

Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active E

21 January 2018

1 reference

Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis

21 January 2018

1 reference

Recurrence of chronic active Epstein-Barr virus infection from donor cells after achieving complete response through allogeneic bone marrow transplantation

21 January 2018

1 reference

Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival

21 January 2018

1 reference

Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils

21 January 2018

1 reference

Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection

21 January 2018

1 reference

Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection

21 January 2018

1 reference

Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection

21 January 2018

1 reference

Characterization of Epstein-Barr virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions.

21 January 2018

1 reference

Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.

21 January 2018

1 reference

Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.

21 January 2018

1 reference

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation

21 January 2018

1 reference

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

21 January 2018

1 reference

Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells

21 January 2018

1 reference

Multicenter evaluation of prototype real-time PCR assays for Epstein-Barr virus and cytomegalovirus DNA in whole blood samples from transplant recipients.

21 January 2018

1 reference

Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.

21 January 2018

1 reference

Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.

21 January 2018

1 reference

Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells

21 January 2018

1 reference

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

Identification of virus-encoded microRNAs

21 January 2018

1 reference

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

21 January 2018

1 reference

Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.

21 January 2018

1 reference

Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation

21 January 2018

1 reference

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.

21 January 2018

1 reference

Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection

21 January 2018

1 reference

Proteasome inhibition: a novel approach to cancer therapy

21 January 2018

1 reference

Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells

21 January 2018

1 reference

Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.

21 January 2018

1 reference

Virus-associated tumor imaging by induction of viral gene expression

21 January 2018

1 reference

Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression

21 January 2018

1 reference

Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PED.12314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528553%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference